Sida Zhao

678 total citations
32 papers, 432 citations indexed

About

Sida Zhao is a scholar working on Molecular Biology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sida Zhao has authored 32 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Hematology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sida Zhao's work include Acute Myeloid Leukemia Research (12 papers), Pituitary Gland Disorders and Treatments (11 papers) and Histone Deacetylase Inhibitors Research (5 papers). Sida Zhao is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Pituitary Gland Disorders and Treatments (11 papers) and Histone Deacetylase Inhibitors Research (5 papers). Sida Zhao collaborates with scholars based in China and United States. Sida Zhao's co-authors include Chunkang Chang, Juan Guo, Youshan Zhao, Chengming Fei, Dong Wu, Yazhuo Zhang, Qingqing Zheng, Chuzhong Li, Xiao Li and Lingyun Wu and has published in prestigious journals such as Blood, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Sida Zhao

28 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sida Zhao China 11 209 123 106 102 64 32 432
Claire Bléchet France 12 194 0.9× 99 0.8× 72 0.7× 164 1.6× 49 0.8× 27 470
Bin Fu China 14 314 1.5× 249 2.0× 163 1.5× 136 1.3× 19 0.3× 29 647
Servé Olieslagers Netherlands 11 210 1.0× 108 0.9× 36 0.3× 75 0.7× 30 0.5× 15 519
Arshad A. Pandith India 14 323 1.5× 37 0.3× 87 0.8× 139 1.4× 77 1.2× 68 604
Marianne Bach Treppendahl Denmark 16 496 2.4× 257 2.1× 77 0.7× 123 1.2× 199 3.1× 24 832
Mohamed Mabed Egypt 12 127 0.6× 105 0.9× 66 0.6× 46 0.5× 13 0.2× 41 401
Emma V. Morris United Kingdom 10 144 0.7× 111 0.9× 48 0.5× 120 1.2× 10 0.2× 14 374
Erica L. Clinkenbeard United States 15 294 1.4× 65 0.5× 52 0.5× 48 0.5× 50 0.8× 33 865
Nariaki Asada Japan 9 207 1.0× 99 0.8× 61 0.6× 56 0.5× 21 0.3× 17 471
Aimalie Hardaway United States 8 187 0.9× 51 0.4× 59 0.6× 179 1.8× 21 0.3× 10 565

Countries citing papers authored by Sida Zhao

Since Specialization
Citations

This map shows the geographic impact of Sida Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sida Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sida Zhao more than expected).

Fields of papers citing papers by Sida Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sida Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sida Zhao. The network helps show where Sida Zhao may publish in the future.

Co-authorship network of co-authors of Sida Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Sida Zhao. A scholar is included among the top collaborators of Sida Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sida Zhao. Sida Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bin, Sida Zhao, Yiyuan Chen, et al.. (2024). HSPB1 promotes tumor invasion by inducing angiogenesis in PitNETs. Endocrine Related Cancer. 31(6).
2.
Guo, Juan, Sida Zhao, Lei Shi, et al.. (2024). Eltrombopag restores proliferative capacity and adipose-osteogenic balance of mesenchymal stromal cells in low-risk myelodysplastic syndromes. European Journal of Pharmacology. 985. 177086–177086.
3.
Yao, Xiaohui, et al.. (2023). Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs. Medicina. 59(2). 373–373. 2 indexed citations
4.
Zhao, Youshan, Zijuan Li, Juan Guo, et al.. (2023). S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression. Acta Biochimica et Biophysica Sinica. 55(2). 194–201. 3 indexed citations
5.
Zhao, Youshan, et al.. (2023). Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes. Leukemia & lymphoma. 65(1). 100–108. 1 indexed citations
6.
Zhao, Sida, Bin Li, Hua Gao, & Yazhuo Zhang. (2023). MiR-320a Acts as a Tumor Suppressor in Somatotroph Pituitary Neuroendocrine Tumors by Targeting BCAT1. Neuroendocrinology. 114(1). 14–24. 2 indexed citations
7.
Zhang, Zheng, et al.. (2022). Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes. Current Oncology. 29(10). 6933–6946.
8.
Zhao, Sida, Yue He, Hongyun Wang, et al.. (2022). Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas. Frontiers in Endocrinology. 13. 863017–863017.
9.
Li, Bin, Sida Zhao, Qiuyue Fang, et al.. (2022). Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma. Frontiers in Surgery. 9. 973834–973834. 9 indexed citations
10.
Zhao, Sida, Jianhua Li, Jie Feng, et al.. (2019). Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas. International Journal of Endocrinology. 2019. 1–12. 28 indexed citations
11.
Zhao, Sida, Bin Li, Chuzhong Li, et al.. (2019). The Apoptosis Regulator 14-3-3η and Its Potential as a Therapeutic Target in Pituitary Oncocytoma. Frontiers in Endocrinology. 10. 797–797. 9 indexed citations
12.
Li, Bin, Jianhua Cheng, Hongyun Wang, et al.. (2019). CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition. Journal of Translational Medicine. 17(1). 336–336. 25 indexed citations
13.
Feng, Jie, Hua Gao, Qi Zhang, et al.. (2019). Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets. Journal of Translational Medicine. 17(1). 291–291. 10 indexed citations
14.
Zhu, Haibo, Jing Guo, Weiyan Xie, et al.. (2019). The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma. Journal of Translational Medicine. 17(1). 354–354. 9 indexed citations
15.
Zheng, Qingqing, Youshan Zhao, Juan Guo, et al.. (2018). Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway. Cell Death and Disease. 9(5). 515–515. 93 indexed citations
16.
Fei, Chengming, Juan Guo, Youshan Zhao, et al.. (2018). Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes. Journal of Translational Medicine. 16(1). 234–234. 7 indexed citations
17.
Feng, Jie, Qi Zhang, Yang Zhou, et al.. (2018). Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma. Frontiers in Endocrinology. 9. 678–678. 29 indexed citations
19.
Zhao, Sida, Youshan Zhao, Juan Guo, et al.. (2017). Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation. Scientific Reports. 7(1). 43849–43849. 13 indexed citations
20.
Zhao, Youshan, Juan Guo, Sida Zhao, et al.. (2017). Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome. Leukemia Research. 58. 55–62. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026